Friday, 24 May 2024

Oncoshot partners with Australian Genomic Cancer Medicine Centre

22 July 2022 | News

As a potential reference model for the rest of the Australian healthcare landscape

Image credit: prnewswire

Image credit: prnewswire

Singapore-based firm Oncoshot has entered into a collaboration agreement with Omico, the Australian Genomic Cancer Medicine Centre. 

As one of the first of its kind in Australia, this collaboration between Omico and Oncoshot is regarded as a potential reference model for the rest of the Australian healthcare landscape when it comes to data sharing between private and public healthcare stakeholders.

As Omico is one of Australia's leading cancer research networks, this partnership will create opportunities for global trial sponsors to leverage real-time aggregated patient insights with biomarker data and present Omico and its network of hospitals as preferred site partners within the region.

Despite its importance for population health planning, basic and clinical research and health industry utilisation, access to health data remains problematic. The ability to securely engage in health information exchange can reinforce the integration and cooperation between public and private healthcare stakeholders to allow both sides to reach healthcare goals together. Furthermore, extending this data sharing with the research circle can provide insights into strategies to better the effectiveness and efficiency of health services while evaluating the influence of new health policies and interventions.


Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account